Product Images Levemir

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 35 images provide visual information about the product associated with Levemir NDC 0169-6438 by Novo Nordisk, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

S:\SMART\LABELING\PRODUCTS\Levemir\FIGURES\Chemical Structure.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 01

S:\SMART\LABELING\PRODUCTS\Levemir\FIGURES\Chemical Structure.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 01

Figure 4A - aa947266 e27c 432b 8e04 c36168d24ddb 06

Figure 4A - aa947266 e27c 432b 8e04 c36168d24ddb 06

Figure 4B - aa947266 e27c 432b 8e04 c36168d24ddb 07

Figure 4B - aa947266 e27c 432b 8e04 c36168d24ddb 07

Figure 6 - aa947266 e27c 432b 8e04 c36168d24ddb 08

Figure 6 - aa947266 e27c 432b 8e04 c36168d24ddb 08

Figure 7 - aa947266 e27c 432b 8e04 c36168d24ddb 09

Figure 7 - aa947266 e27c 432b 8e04 c36168d24ddb 09

Figure 8 - aa947266 e27c 432b 8e04 c36168d24ddb 10

Figure 8 - aa947266 e27c 432b 8e04 c36168d24ddb 10

Figure 9 - aa947266 e27c 432b 8e04 c36168d24ddb 11

Figure 9 - aa947266 e27c 432b 8e04 c36168d24ddb 11

Figure 10 - aa947266 e27c 432b 8e04 c36168d24ddb 12

Figure 10 - aa947266 e27c 432b 8e04 c36168d24ddb 12

Figure 1 - aa947266 e27c 432b 8e04 c36168d24ddb 13

Figure 1 - aa947266 e27c 432b 8e04 c36168d24ddb 13

Step 1 Fig B.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 28

Step 1 Fig B.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 28

Step 2 Fig C.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 29

Step 2 Fig C.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 29

Figure D - aa947266 e27c 432b 8e04 c36168d24ddb 30

Figure D - aa947266 e27c 432b 8e04 c36168d24ddb 30

Figure E - aa947266 e27c 432b 8e04 c36168d24ddb 31

Figure E - aa947266 e27c 432b 8e04 c36168d24ddb 31

Figure F - aa947266 e27c 432b 8e04 c36168d24ddb 32

Figure F - aa947266 e27c 432b 8e04 c36168d24ddb 32

Figure G - aa947266 e27c 432b 8e04 c36168d24ddb 33

Figure G - aa947266 e27c 432b 8e04 c36168d24ddb 33

Step 7 Fig H.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 34

Step 7 Fig H.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 34

Step 8 Fig I.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 35

Step 8 Fig I.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 35

Step 9 Fig J.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 36

Step 9 Fig J.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 36

Step 10 Fig K.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 37

Step 10 Fig K.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 37

Step 10 Fig L - aa947266 e27c 432b 8e04 c36168d24ddb 38

Step 10 Fig L - aa947266 e27c 432b 8e04 c36168d24ddb 38

Step 11 Fig M - aa947266 e27c 432b 8e04 c36168d24ddb 39

Step 11 Fig M - aa947266 e27c 432b 8e04 c36168d24ddb 39

Step 12 Fig N.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 40

Step 12 Fig N.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 40

Step 13 Fig O.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 41

Step 13 Fig O.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 41

Step 13 Fig P.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 42

Step 13 Fig P.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 42

Step 14 Fig Q.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 43

Step 14 Fig Q.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 43

Step 15 Fig S.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 45

Step 15 Fig S.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 45

Step 16 Fig T.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 46

Step 16 Fig T.jpg - aa947266 e27c 432b 8e04 c36168d24ddb 46

FlexTouch QR Code - aa947266 e27c 432b 8e04 c36168d24ddb 50

FlexTouch QR Code - aa947266 e27c 432b 8e04 c36168d24ddb 50

Image of Levemir vial carton - image 01

Image of Levemir vial carton - image 01

FlexTouch - image 02

FlexTouch - image 02

Needle components. - image 03

Needle components. - image 03

Figure A FlexTouch pen components. - image 04

Figure A FlexTouch pen components. - image 04

Step 15 Figure R - image 05

Step 15 Figure R - image 05

Figure 2: Activity Profiles in Patients with Type 1 Diabetes - image 06

Figure 2: Activity Profiles in Patients with Type 1 Diabetes - image 06

The text seems to be a graph showing pharmacodynamic parameters for Levemir, with glucose infusion rate and time since insulin injection on the x-axis and y-axis respectively. The graph is divided into two lines, one for 0.2 Units/kg dose and the other for 0.4 Units/kg dose. The graph also shows the area under the curve for glucose infusion rate and the maximum glucose infusion rate.*

Figure 3: Activity Profiles in Patients with Type 2 Diabetes - image 07

Figure 3: Activity Profiles in Patients with Type 2 Diabetes - image 07

This is a chart showing pharmacodynamic parameters for Levemir, a drug used to treat diabetes. The chart displays the Glucose Infusion Rate (mg/kg/min) over time since insulin injection (hours) for two different doses of Levemir (0.6 Units/kg and 1.2 Units/kg). The graph also includes two pharmacodynamic parameters: AUCa or Area Under Curve Glucose Infusion Rate and GIRmax or Maximum Glucose Infusion Rate.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.